Schrodinger Inc (SDGR)

10:32 AM

Schrödinger to Present Phase 1 Clinical Data on MALT1 Inhibitor - GuruFocus

10:32 AM

May 09, 2025

Schrödinger, Inc. (NASDAQ:SDGR) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 09, 2025

Schrödinger First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

May 09, 2025

May 08, 2025

Schrödinger, Inc. Reports Strong Q1 Growth Amid Challenges - TipRanks

May 08, 2025

May 08, 2025

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... - Yahoo Finance

May 08, 2025

May 08, 2025

Schrodinger Inc (SDGR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic Advancements - GuruFocus

May 08, 2025

May 08, 2025

Decoding Schrodinger Inc (SDGR): A Strategic SWOT Insight - GuruFocus

May 08, 2025

May 07, 2025

Schrödinger Q1 2025 slides: revenue jumps 63%, clinical readouts on horizon - Investing.com Canada

May 07, 2025

May 07, 2025

Schrödinger projects strong 2025 revenue growth with $45M-$50M in drug discovery - MSN

May 07, 2025

May 07, 2025

Schrodinger Inc (SDGR) Q1 2025 Earnings: Revenue Surges to $59.6M, Beating Estimates; Net Loss Widens to $59.8M - GuruFocus

May 07, 2025

May 07, 2025

Schrodinger, Inc. (SDGR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 07, 2025

May 07, 2025

Schrodinger Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025

May 07, 2025

Earnings call transcript: Schrodinger Q1 2025 beats EPS expectations, stock rises - Investing.com

May 07, 2025

May 07, 2025

Schrodinger (SDGR) Surpasses Revenue Expectations with Strong Gr - GuruFocus

May 07, 2025

May 07, 2025

Schrodinger (SDGR) Reaffirms 2025 Financial Projections | SDGR Stock News - GuruFocus

May 07, 2025

May 07, 2025

Earnings Flash (SDGR) SCHRODINGER Reports Q1 Revenue $59.6M, vs. FactSet Est of $54.7M - marketscreener.com

May 07, 2025

May 07, 2025

Schrodinger earnings beat by $0.10, revenue topped estimates - Investing.com

May 07, 2025

May 07, 2025

Schrödinger Reports Strong First Quarter 2025 Financial Results - Eagle-Tribune

May 07, 2025

May 07, 2025

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)? - Yahoo Finance

May 07, 2025

May 05, 2025

AI Healthcare Boom Gains Speed as Regulators and Innovators Align - Benzinga

May 05, 2025

May 05, 2025

Schrödinger to Present at BofA Securities 2025 Healthcare Conference - 01net

May 05, 2025

May 05, 2025

Schrödinger to Present at BofA Securities 2025 Healthcare Conference | SDGR Stock News - GuruFocus

May 05, 2025

May 04, 2025

Learn to Evaluate (SDGR) using the Charts - news.stocktradersdaily.com

May 04, 2025

May 01, 2025

Top 5 AI & Digital Biotech Companies (May 2025) - Securities.io

May 01, 2025

Apr 30, 2025

Schrödinger Demonstrates Corporate Sustainability Progress in 2024 Report - ReportAlert

Apr 30, 2025

Apr 29, 2025

Schrodinger Inc (SDGR) Shares Gap Down to $25.585 on Apr 28 - GuruFocus

Apr 29, 2025

Apr 28, 2025

Schrödinger, Inc. (NASDAQ:SDGR) Looks Just Right With A 33% Price Jump - simplywall.st

Apr 28, 2025

Apr 28, 2025

Schrödinger Presents New Preclinical Data at AACR Annual Meeting - 01net

Apr 28, 2025

Apr 23, 2025

Schrödinger, Inc. (SDGR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential - Insider Monkey

Apr 23, 2025

Apr 23, 2025

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 | SDGR Stock News - GuruFocus

Apr 23, 2025

Apr 23, 2025

Schrödinger to Announce First Quarter 2025 Financial Results on May 7 - marketscreener.com

Apr 23, 2025

Apr 21, 2025

3 Momentum Stocks That Could Soar Post-Market Volatility - MarketBeat

Apr 21, 2025

Apr 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - 01net

Apr 18, 2025

Apr 18, 2025

Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | SDGR Stock News - GuruFocus

Apr 18, 2025

Apr 17, 2025

Schrödinger (NASDAQ:SDGR) shareholders are up 29% this past week, but still in the red over the last five years - simplywall.st

Apr 17, 2025

Apr 16, 2025

Schrodinger (SDGR) Moves 27.4% Higher: Will This Strength Last? - MSN

Apr 16, 2025

Apr 16, 2025

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 26% Undervalued - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Schrodinger price target raised to $32 from $30 at KeyBanc - TipRanks

Apr 16, 2025

Apr 15, 2025

Schrodinger’s Karen Akinsanya sells $419,570 in stock By Investing.com - Investing.com South Africa

Apr 15, 2025

Apr 15, 2025

Schrodinger’s Karen Akinsanya sells $419,570 in stock - Investing.com

Apr 15, 2025

Apr 15, 2025

Schrodinger issues statement on FDA phasing out animal testing requirement - TipRanks

Apr 15, 2025

Apr 15, 2025

FDA recent move marks paradigm shift in drug development, boosting Schrödinger (SDGR) and other biotech stocks - Investorsobserver

Apr 15, 2025

Apr 14, 2025

Schrodinger (SDGR) Backs FDA's Initiative to Cut Animal Testing in Drug Development | SDGR Stock News - GuruFocus

Apr 14, 2025

Apr 14, 2025

Schrödinger's Statement Regarding FDA Plan to Phase Out Animal T - GuruFocus

Apr 14, 2025

Apr 14, 2025

Schrödinger backs FDA’s move away from animal testing By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Schrodinger to Launch Predictive Toxicology Tool in H2 - marketscreener.com

Apr 14, 2025

Apr 14, 2025

Schrödinger’s Statement Regarding FDA Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs - 01net

Apr 14, 2025